Quality of life assessment using EORTC QLQ questionnaires in the prostate cancer population treated with radical prostatectomy: a systematic review

Health-related quality of life in prostate cancer patients in the Silesian Province (Poland) before and after radical prostatectomy – a longitudinal observational pilot study

“…The survey used Polish-language versions of the standardized and validated questionnaires EORTC QLQ-C30 (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Items) and EORTC QLQ-PR25 (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Prostate 25 Items). The use of these questionnaires has been approved by the European Organization for Research and Treatment of Cancer (Brussels, Belgium), and they are considered to be high-quality tools by numerous international organizations and associations working for people with cancer [9,13]. The survey also included authors' own questions regarding patients' age, height, weight, marital status, place of residence, level of education, use of tobacco, and alcohol consumption.…”

“…The EORTC QLQ-C30 questionnaire is made up of 30 questions grouped into nine symptom scales (fatigue, nausea, pain, dyspnea, insomnia, appetite loss, constipation, diarrhea, and financial difficulties), five functional scales (emotional, physical, role, social, and cognitive), and one global health status scale [9,13,14]. The EORTC QLQ-PR25 questionnaire, which is a supplementary module for prostate cancer patients, consists of 25 questions divided into four symptom scales (urinary, incontinence aid, bowel, and hormonal treatment), and two functional scales concerning sexual activity and functioning.…”

“…Changes in the quality of life are commonly observed in men with prostate cancer [9]. As early as the point of diagnosis, reduction in the quality of life may be observed on the emotional, cognitive and social levels, among others [10].…”

“…As early as the point of diagnosis, reduction in the quality of life may be observed on the emotional, cognitive and social levels, among others [10]. This reduction not only results from the fact that patients are confronted with the disease itself, but is also associated with patients' beliefs, and the beliefs of those in their immediate environment, resulting from their understanding of prostate cancer and its treatment [9,10,11]. Quality of life has therefore become not only an integral part of the comprehensive assessment of cancer treatment outcomes, but also an important component in the treatment selection itself.…”

Two-year quality of life after robot-assisted radical prostatectomy according to pentafecta criteria and cancer of the prostate risk assessment (CAPRA-S)

“…mean change of individual EORTC QLQ-C30 scales over time and did not stratify according to specific functional or oncological scenarios. Moreover, most series omitted multivariable analyses 19 , 21 – 24 and relied on ORP patients 19 , 21 , 22 . In general, comprehensive data on RARP and EORTC QLQ-C30 is sparse.…”